Tilray Brands (TLRY) Projected to Post Quarterly Earnings on Monday

Tilray Brands (NASDAQ:TLRY - Get Free Report) is anticipated to issue its Q4 2025 quarterly earnings data after the market closes on Monday, July 28th. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $250.41 million for the quarter.

Tilray Brands Stock Performance

TLRY opened at $0.62 on Monday. The stock's 50 day moving average price is $0.46 and its two-hundred day moving average price is $0.67. The firm has a market capitalization of $625.34 million, a P/E ratio of -0.59 and a beta of 1.82. The company has a quick ratio of 1.61, a current ratio of 2.62 and a debt-to-equity ratio of 0.12. Tilray Brands has a 12-month low of $0.35 and a 12-month high of $2.15.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Piper Sandler cut their price objective on shares of Tilray Brands from $2.00 to $1.00 and set a "neutral" rating for the company in a research report on Wednesday, April 9th. Wall Street Zen cut Tilray Brands to a "strong sell" rating in a report on Saturday, July 5th. Finally, Roth Capital reissued a "neutral" rating on shares of Tilray Brands in a report on Monday, April 14th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Tilray Brands has a consensus rating of "Hold" and a consensus price target of $1.92.

Institutional Trading of Tilray Brands

A hedge fund recently raised its stake in Tilray Brands stock. AQR Capital Management LLC increased its stake in Tilray Brands, Inc. (NASDAQ:TLRY - Free Report) by 1,839.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 607,054 shares of the company's stock after buying an additional 575,757 shares during the quarter. AQR Capital Management LLC owned approximately 0.06% of Tilray Brands worth $399,000 as of its most recent SEC filing. 9.35% of the stock is owned by institutional investors.

Tilray Brands Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.